Press Releases

16 Nov '12
Three years ago,  malady  the FDA approved Johnson & Johnson’s thermocool, the first in a series of ablation catheters specifically designed to halt atrial fibrillation. Despite these advances, the long-term success rates of catheter ablation procedures remain low, opening the door for start-ups to
20 Jul '11
New medical technology company focused on developing a breakthrough device for real time mapping of Atrial Fibrillation 8th August 2011, San Diego, USA:  – Index Ventures, together with private investors, has invested an initial funding of $1 million in Acutus Medical, a newly founded medical
Displaying 41 - 44 of 44